Our updated estimates suggest that newly infected people living with HIV are more likely to have lower initial CD4 counts, and progress through infection stages more rapidly, but experience lower HIV‐related mortality rates in most stages, consistent with other analyses of CD4 progression in HIV seroconverter cohort studies [9, 10, 11]. The gene discussed is CD4; the disease is infection.